Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
揭开层面：通过分析师见解探索阿尼卡疗法
In the latest quarter, 4 analysts provided ratings for Anika Therapeutics (NASDAQ:ANIK), showcasing a mix of bullish and bearish perspectives.
在最近一个季度中，4位分析师为Anika Therapeutics（纳斯达克股票代码：ANIK）提供了评级，显示了看涨和看跌的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Anika Therapeutics, presenting an average target of $30.0, a high estimate of $37.00, and a low estimate of $22.00. Consistency is reflected as the current average remains at the same level as the previous average price target.
在评估12个月目标股价时，分析师公布了对Anika Therapeutics的见解，将平均目标股价定为30.0美元，最高估计为37.00美元，低估值为22.00美元。一致性体现在当前的平均水平与之前的平均目标价格保持在同一水平。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The standing of Anika Therapeutics among financial...
通过对分析师近...
登录免费看全文
登录/注册